JP2007500720A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007500720A5 JP2007500720A5 JP2006522096A JP2006522096A JP2007500720A5 JP 2007500720 A5 JP2007500720 A5 JP 2007500720A5 JP 2006522096 A JP2006522096 A JP 2006522096A JP 2006522096 A JP2006522096 A JP 2006522096A JP 2007500720 A5 JP2007500720 A5 JP 2007500720A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- independently selected
- group
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 49
- 239000000203 mixture Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims 104
- 229910052739 hydrogen Inorganic materials 0.000 claims 94
- 239000001257 hydrogen Substances 0.000 claims 94
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 64
- 125000003710 aryl alkyl group Chemical group 0.000 claims 44
- 150000002431 hydrogen Chemical class 0.000 claims 30
- -1 chloro, methyl Chemical group 0.000 claims 29
- 125000000753 cycloalkyl group Chemical group 0.000 claims 27
- 125000001072 heteroaryl group Chemical group 0.000 claims 26
- 125000000623 heterocyclic group Chemical group 0.000 claims 26
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 25
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 25
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 24
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 24
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims 21
- 125000004093 cyano group Chemical group *C#N 0.000 claims 20
- 125000005020 hydroxyalkenyl group Chemical group 0.000 claims 18
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 16
- 125000001153 fluoro group Chemical group F* 0.000 claims 15
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 15
- 125000005843 halogen group Chemical group 0.000 claims 14
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 14
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 14
- 125000001424 substituent group Chemical group 0.000 claims 14
- 125000004385 trihaloalkyl group Chemical group 0.000 claims 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 13
- 125000003118 aryl group Chemical group 0.000 claims 12
- 102000016553 Stearoyl-CoA Desaturase Human genes 0.000 claims 11
- 108010028096 Stearoyl-CoA Desaturase Proteins 0.000 claims 11
- 201000010099 disease Diseases 0.000 claims 11
- 125000004952 trihaloalkoxy group Chemical group 0.000 claims 11
- 125000005418 aryl aryl group Chemical group 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 10
- 125000003367 polycyclic group Chemical group 0.000 claims 10
- 239000003795 chemical substances by application Substances 0.000 claims 9
- 229940079593 drugs Drugs 0.000 claims 9
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 8
- 125000004043 oxo group Chemical group O=* 0.000 claims 7
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 6
- 125000006448 cycloalkyl cycloalkyl group Chemical group 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000011780 sodium chloride Substances 0.000 claims 6
- 125000005349 heteroarylcycloalkyl group Chemical group 0.000 claims 5
- 239000000651 prodrug Substances 0.000 claims 5
- 229940002612 prodrugs Drugs 0.000 claims 5
- 230000002159 abnormal effect Effects 0.000 claims 4
- 125000001544 thienyl group Chemical group 0.000 claims 4
- 206010012601 Diabetes mellitus Diseases 0.000 claims 2
- IEGIIHBIJYVXKK-UHFFFAOYSA-N FC1=CC=C(C=C1)CCC[NH-] Chemical compound FC1=CC=C(C=C1)CCC[NH-] IEGIIHBIJYVXKK-UHFFFAOYSA-N 0.000 claims 2
- 208000004930 Fatty Liver Diseases 0.000 claims 2
- 206010019708 Hepatic steatosis Diseases 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 206010053219 Non-alcoholic steatohepatitis Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 2
- ANKCWFZVDMOTOE-UHFFFAOYSA-N 2-(4-fluorophenyl)ethylazanide Chemical compound [NH-]CCC1=CC=C(F)C=C1 ANKCWFZVDMOTOE-UHFFFAOYSA-N 0.000 claims 1
- ZUKJVTQSCASKTC-UHFFFAOYSA-N 2-phenylethylazanide Chemical compound [NH-]CCC1=CC=CC=C1 ZUKJVTQSCASKTC-UHFFFAOYSA-N 0.000 claims 1
- HIFQMCNIAGNNJP-UHFFFAOYSA-N 3-phenylpropylazanide Chemical compound [NH-]CCCC1=CC=CC=C1 HIFQMCNIAGNNJP-UHFFFAOYSA-N 0.000 claims 1
- PAGYNCILTPYJFM-UHFFFAOYSA-N C(CC(C)C)[NH-] Chemical compound C(CC(C)C)[NH-] PAGYNCILTPYJFM-UHFFFAOYSA-N 0.000 claims 1
- IJTNQXJUSHVJCY-UHFFFAOYSA-N CCCCC[NH-] Chemical compound CCCCC[NH-] IJTNQXJUSHVJCY-UHFFFAOYSA-N 0.000 claims 1
- 206010058108 Dyslipidaemia Diseases 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 206010022489 Insulin resistance Diseases 0.000 claims 1
- 206010061227 Lipid metabolism disease Diseases 0.000 claims 1
- FGOUAQGATIHMQX-UHFFFAOYSA-N N-(2-phenylethyl)-5-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]pyrimidine-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)N1CCN(C=2C=NC(=NC=2)C(=O)NCCC=2C=CC=CC=2)CC1 FGOUAQGATIHMQX-UHFFFAOYSA-N 0.000 claims 1
- DAXBFBDXGVPOQZ-UHFFFAOYSA-N N-(3-methylbutyl)-2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]pyrimidine-5-carboxamide Chemical compound N1=CC(C(=O)NCCC(C)C)=CN=C1N1CCN(C(=O)C=2C(=CC=CC=2)C(F)(F)F)CC1 DAXBFBDXGVPOQZ-UHFFFAOYSA-N 0.000 claims 1
- BDBOKIVURAOEDF-UHFFFAOYSA-N N-(3-methylbutyl)-4-(trifluoromethyl)-2-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]pyrimidine-5-carboxamide Chemical compound N1=C(C(F)(F)F)C(C(=O)NCCC(C)C)=CN=C1N1CCN(C(=O)C=2C(=CC=CC=2)C(F)(F)F)CC1 BDBOKIVURAOEDF-UHFFFAOYSA-N 0.000 claims 1
- UVTGETXCJPTQCB-UHFFFAOYSA-N N-(3-phenylpropyl)-5-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]pyrimidine-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)N1CCN(C=2C=NC(=NC=2)C(=O)NCCCC=2C=CC=CC=2)CC1 UVTGETXCJPTQCB-UHFFFAOYSA-N 0.000 claims 1
- PNQGAOSCJVLAFG-UHFFFAOYSA-N N-benzyl-5-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]pyrimidine-2-carboxamide Chemical compound FC(F)(F)C1=CC=CC=C1C(=O)N1CCN(C=2C=NC(=NC=2)C(=O)NCC=2C=CC=CC=2)CC1 PNQGAOSCJVLAFG-UHFFFAOYSA-N 0.000 claims 1
- OWUBZQNYYJEHEA-UHFFFAOYSA-N N-hexyl-5-[4-[2-(trifluoromethyl)benzoyl]piperazin-1-yl]pyrimidine-2-carboxamide Chemical compound C1=NC(C(=O)NCCCCCC)=NC=C1N1CCN(C(=O)C=2C(=CC=CC=2)C(F)(F)F)CC1 OWUBZQNYYJEHEA-UHFFFAOYSA-N 0.000 claims 1
- YBWDYDRHSKKFSB-UHFFFAOYSA-N O(C1=CC=CC=C1)CC[NH-] Chemical compound O(C1=CC=CC=C1)CC[NH-] YBWDYDRHSKKFSB-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000001404 mediated Effects 0.000 claims 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 8
- 0 CC1=*I=C(N(C*2)C(*)(*)C(*)(*)N(**)C2(*)C2*=C2)N=I1 Chemical compound CC1=*I=C(N(C*2)C(*)(*)C(*)(*)N(**)C2(*)C2*=C2)N=I1 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- HWCKAMAVEWVBDO-UHFFFAOYSA-N 5-chloropyrazin-2-amine Chemical compound NC1=CN=C(Cl)C=N1 HWCKAMAVEWVBDO-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49109503P | 2003-07-30 | 2003-07-30 | |
US60/491,095 | 2003-07-30 | ||
PCT/US2004/024658 WO2005011657A2 (en) | 2003-07-30 | 2004-07-29 | Piperazine derivatives and their use as therapeutic agents |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2007500720A JP2007500720A (ja) | 2007-01-18 |
JP2007500720A5 true JP2007500720A5 (US07981874-20110719-C00313.png) | 2007-09-13 |
JP4838128B2 JP4838128B2 (ja) | 2011-12-14 |
Family
ID=34115467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006522096A Expired - Fee Related JP4838128B2 (ja) | 2003-07-30 | 2004-07-29 | ピペラジン誘導体および治療剤としてのその用途 |
Country Status (22)
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7517884B2 (en) | 1998-03-30 | 2009-04-14 | Kalypsys Inc. | Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
BR0112969A (pt) * | 2000-08-04 | 2004-06-22 | Dmi Biosciences Inc | Método de utilização de dicetopiperazinas e composições contendo-as |
KR20120091266A (ko) | 2003-05-15 | 2012-08-17 | 디엠아이 바이오사이언시스, 인크 | T-세포 매개성 질환의 치료 방법 |
MXPA06000940A (es) * | 2003-07-24 | 2006-03-30 | Euro Celtique Sa | Agentes terapeuticos utiles para el tratamiento de dolor. |
US7759348B2 (en) | 2003-07-30 | 2010-07-20 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
CA2533900A1 (en) * | 2003-07-30 | 2005-02-10 | Xenon Pharmaceuticals Inc. | Pyridyl derivatives and their use as therapeutic agents |
US7754711B2 (en) | 2003-07-30 | 2010-07-13 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives and their use as therapeutic agents |
ES2375134T3 (es) | 2003-07-30 | 2012-02-27 | Xenon Pharmaceuticals Inc. | Derivados de piperazina y su uso como agentes terapéuticos. |
JP5094398B2 (ja) | 2004-09-20 | 2012-12-12 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 複素環式誘導体およびステアロイル−CoAデサチュラーゼのメディエータとしてのそれらの使用 |
CN101084207A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途 |
US7829712B2 (en) | 2004-09-20 | 2010-11-09 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase |
DE602005025924D1 (en) * | 2004-09-20 | 2011-02-24 | Xenon Pharmaceuticals Inc | Royl-coa-desaturase |
EP2289510A1 (en) | 2004-09-20 | 2011-03-02 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
AU2005329423A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
EP1807085B1 (en) | 2004-09-20 | 2013-08-21 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
MX2007003321A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
US7547698B2 (en) * | 2004-09-20 | 2009-06-16 | Xenon Pharmaceuticals Inc. | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD) |
MX2007005205A (es) | 2004-10-29 | 2007-05-11 | Kalypsys Inc | Compuestos biciclicos sulfonilo-sustituidos como moduladores de receptores activados por el proliferador de la peroxisoma. |
EP1866314B1 (en) | 2005-02-16 | 2010-09-15 | NeuroSearch A/S | Novel diazabicyclic aryl derivatives and their medical use |
AR053710A1 (es) | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
MY158766A (en) | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
WO2006125181A2 (en) * | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Piperidine derivatives and their use as stearoyl-coa desaturase modulators |
WO2007046867A2 (en) * | 2005-05-19 | 2007-04-26 | Xenon Pharmaceuticals Inc. | Piperidine derivatives and their uses as therapeutic agents |
WO2006125178A2 (en) * | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Tricyclic pyridazine compounds and their uses as therapeutic agents |
WO2006125180A1 (en) * | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Piperazine derivatives and their uses as therapeutic agents |
WO2006125179A1 (en) * | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Tricyclic compounds and their uses as therapeutic agents |
WO2007044085A2 (en) * | 2005-05-19 | 2007-04-19 | Xenon Pharmaceuticals Inc. | Heteroaryl compounds and their uses as therapeutic agents |
WO2006125194A2 (en) * | 2005-05-19 | 2006-11-23 | Xenon Pharmaceuticals Inc. | Piperazine derivatives and their uses as therapeutic agents |
CN101208089A (zh) | 2005-06-03 | 2008-06-25 | 泽农医药公司 | 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 |
CA2624383C (en) | 2005-10-25 | 2014-03-11 | Kalypsys, Inc. | Salts of modulators of ppar and methods of treating metabolic disorders |
US20090291955A1 (en) * | 2005-11-15 | 2009-11-26 | Crane Sheldon N | Azacyclohexane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase |
WO2007071023A1 (en) * | 2005-12-20 | 2007-06-28 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
PA8713501A1 (es) | 2006-02-07 | 2009-09-17 | Wyeth Corp | INHIBIDORES DE 11-BETA HIDROXIESTEROIDE DEHIDROGENASA - 11ßHSD1 |
WO2007143597A2 (en) | 2006-06-05 | 2007-12-13 | Novartis Ag | Organic compounds |
WO2008003753A1 (en) * | 2006-07-07 | 2008-01-10 | Biovitrum Ab (Publ) | Pyrazolo [1,5-a] pyrimidine analogs for use as inhibitors of stearoyl-coa desaturase (scd) activity |
CN101506203B (zh) | 2006-08-24 | 2013-10-16 | 诺瓦提斯公司 | 治疗代谢病、心血管病和其他病症的作为硬脂酰辅酶a脱饱和酶(scd)抑制剂的2-(吡嗪-2-基)-噻唑和2-(1h-吡唑-3-基)-噻唑衍生物及相关化合物 |
US7732453B2 (en) * | 2006-10-05 | 2010-06-08 | Gilead Palo Alto, Inc. | Pyrido[2,3-B] pyrazin-3(4H)-ones for use as stearoyl CoA desaturase inhibitors |
JP5460324B2 (ja) | 2006-10-12 | 2014-04-02 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 治療剤としてのスピロ−オキシインドール化合物の使用 |
WO2008091863A1 (en) | 2007-01-23 | 2008-07-31 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
AR064965A1 (es) * | 2007-01-26 | 2009-05-06 | Merck Frosst Canada Inc | Derivados de azacicloalcanos como inhibidores de estearoil - coenzima a delta -9 desaturasa |
US8575167B2 (en) | 2007-02-06 | 2013-11-05 | Takeda Pharmaceutical Company Limited | Spiro compounds having stearoyl-CoA desaturase action |
JP2008239616A (ja) * | 2007-02-28 | 2008-10-09 | Iyaku Bunshi Sekkei Kenkyusho:Kk | Hdl上昇剤 |
US20080255153A1 (en) * | 2007-03-28 | 2008-10-16 | Biovitrum Ab (Publ) | New compounds |
WO2008120759A1 (ja) * | 2007-03-30 | 2008-10-09 | Japan Tobacco Inc. | ウレア化合物およびその用途 |
ME02123B (me) | 2007-04-27 | 2014-08-29 | Purdue Pharma Lp | Antagonisti trpv1 i njihova upotreba |
US9321806B2 (en) | 2007-05-16 | 2016-04-26 | University Of Maryland, College Park | Methods for recovery of leaf proteins |
WO2008157844A1 (en) * | 2007-06-21 | 2008-12-24 | Forest Laboratories Holdings Limited | Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase |
GB0715055D0 (en) * | 2007-08-02 | 2007-09-12 | Smithkline Beecham Corp | Compounds |
US8242286B2 (en) | 2007-08-08 | 2012-08-14 | Medicis Pharmaceutical Corporation | Phenoxy-pyrrolidine derivative and its use and compositions |
ES2499018T3 (es) * | 2007-09-20 | 2014-09-26 | Irm Llc | Compuestos y composiciones como moduladores de la actividad de GPR119 |
WO2009037542A2 (en) | 2007-09-20 | 2009-03-26 | Glenmark Pharmaceuticals, S.A. | Spirocyclic compounds as stearoyl coa desaturase inhibitors |
GB0722077D0 (en) * | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
JP2011525478A (ja) * | 2008-03-20 | 2011-09-22 | フォレスト・ラボラトリーズ・ホールディングス・リミテッド | ステアロイル−CoAデサチュラーゼの阻害剤としての新規ピペラジン誘導体 |
EP2300011A4 (en) | 2008-05-27 | 2012-06-20 | Dmi Life Sciences Inc | METHODS AND THERAPEUTIC COMPOUNDS |
RU2011119626A (ru) | 2008-10-17 | 2012-11-27 | Ксенон Фармасьютикалз Инк. | Спирооксиндольные соединения и их применение в качестве терапевтичеких средств |
CA2741024A1 (en) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
US20100160323A1 (en) * | 2008-12-23 | 2010-06-24 | Alexander Bischoff | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
WO2010094120A1 (en) | 2009-02-17 | 2010-08-26 | Merck Frosst Canada Ltd. | Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
GB0907425D0 (en) * | 2009-04-29 | 2009-06-10 | Glaxo Group Ltd | Compounds |
AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
EP2459568A4 (en) | 2009-07-28 | 2013-02-27 | Merck Frosst Canada Ltd | NOVEL SPIRO COMPOUNDS USEFUL AS DELTA-9 DEATURASE STEAROYL COENZYME INHIBITORS |
WO2011030139A1 (en) | 2009-09-11 | 2011-03-17 | Astrazeneca Ab | 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators |
MY165579A (en) | 2009-10-14 | 2018-04-05 | Xenon Pharmaceuticals Inc | Synthetic methods for spiro-oxindole compounds |
US9504671B2 (en) | 2010-02-26 | 2016-11-29 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
WO2012033792A2 (en) | 2010-09-07 | 2012-03-15 | Dmi Acquisition Corp. | Treatment of diseases |
EP2723732B1 (en) | 2011-06-22 | 2017-01-18 | Purdue Pharma LP | Trpv1 antagonists including dihydroxy substituent and uses thereof |
JP6203734B2 (ja) | 2011-10-10 | 2017-09-27 | アンピオ ファーマシューティカルズ,インコーポレイテッド | 変形性関節疾患の治療 |
BR112014007657A2 (pt) | 2011-10-10 | 2017-04-11 | Ampio Pharmaceuticals Inc | dispositivos médicos implantáveis com tolerância imune aperfeiçoada e métodos para produção e implantação |
EA201490737A1 (ru) | 2011-10-28 | 2014-09-30 | Ампио Фармасьютикалз, Инк. | Лечение ринита |
WO2013134546A1 (en) | 2012-03-07 | 2013-09-12 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
WO2013175474A2 (en) | 2012-05-22 | 2013-11-28 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Selective inhibitors of undifferentiated cells |
WO2014145729A2 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
EP3105216B1 (en) | 2014-02-14 | 2018-10-10 | Takeda Pharmaceutical Company Limited | Pyrazine modulators of gpr6 |
RU2020136589A (ru) | 2014-08-18 | 2020-12-24 | Ампио Фармасьютикалз, Инк. | Лечение дегенеративных заболеваний суставов |
TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
WO2016209969A1 (en) | 2015-06-22 | 2016-12-29 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
US11970486B2 (en) | 2016-10-24 | 2024-04-30 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
EP3566055A4 (en) | 2017-01-06 | 2020-12-02 | Yumanity Therapeutics, Inc. | TREATMENT METHODS FOR NEUROLOGICAL DISORDERS |
EP3700934A4 (en) | 2017-10-24 | 2021-10-27 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THESE COMPOUNDS |
CN108570039B (zh) * | 2018-04-25 | 2022-09-23 | 上海美迪西生物医药股份有限公司 | 一类具有抑制抗凋亡蛋白活性的化合物及其制备和应用 |
CN115772127B (zh) * | 2023-01-31 | 2023-05-16 | 山东佰隆医药有限公司 | 一种合成2-氰基-5-溴嘧啶的方法 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA983493A (en) * | 1972-10-11 | 1976-02-10 | Gilbert Regnier | Procede de preparation des derives du benzodioxole |
DE2341925A1 (de) * | 1973-08-20 | 1975-03-06 | Thomae Gmbh Dr K | Neue pyrimidinderivate und verfahren zu ihrer herstellung |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
JPS6143173A (ja) * | 1984-08-06 | 1986-03-01 | Mitsui Petrochem Ind Ltd | 新規ピリミジン誘導体およびその製法 |
JPS6187672A (ja) * | 1984-10-08 | 1986-05-06 | Mitsui Petrochem Ind Ltd | 新規ピリミジン誘導体 |
US4734418A (en) * | 1984-12-14 | 1988-03-29 | Mitsui Petrochemical Industries, Ltd. | Quinazoline compounds and antihypertensives |
JPS61238784A (ja) * | 1985-04-17 | 1986-10-24 | Sumitomo Seiyaku Kk | コハク酸イミド誘導体及びその酸付加塩 |
WO1987004928A1 (en) * | 1986-02-24 | 1987-08-27 | Mitsui Petrochemical Industries, Ltd. | Agents for treating neurophathy |
US5681956A (en) * | 1990-12-28 | 1997-10-28 | Neurogen Corporation | 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
FR2701260B1 (fr) * | 1993-02-05 | 1995-05-05 | Esteve Labor Dr | Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments. |
EP0793653A1 (en) * | 1994-11-23 | 1997-09-10 | Neurogen Corporation | Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
US6288230B1 (en) * | 1998-09-29 | 2001-09-11 | Neurogen Corporation | 2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands |
ATE475718T1 (de) | 2000-02-24 | 2010-08-15 | Xenon Pharmaceuticals Inc | Stearoyl-coa-desaturase zur identifizierung von triglyceridreduktionstherapeutika |
GB0013383D0 (en) * | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Therapeutic benzamide derivatives |
ES2292607T3 (es) | 2000-07-27 | 2008-03-16 | Eli Lilly And Company | Amidas heterociclicas sustituidas. |
CA2430987A1 (en) | 2000-09-26 | 2002-04-04 | Xenon Genetics, Inc. | Methods and compositions employing a novel stearoyl-coa desaturase-hscd5 |
WO2003037862A1 (fr) * | 2001-10-30 | 2003-05-08 | Nippon Shinyaku Co., Ltd. | Derives amide, et medicaments correspondants |
AU2002350172A1 (en) * | 2001-12-07 | 2003-06-23 | Eli Lilly And Company | Substituted heterocyclic carboxamides with antithrombotic activity |
AU2003202115A1 (en) * | 2002-02-12 | 2003-09-04 | Pfizer Inc. | Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh) |
WO2003076401A1 (en) | 2002-03-13 | 2003-09-18 | Janssen Pharmaceutica N.V. | Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
KR20040090979A (ko) | 2002-03-13 | 2004-10-27 | 얀센 파마슈티카 엔.브이. | 히스톤 데아세틸레이즈의 신규한 억제제 |
CA2476586C (en) * | 2002-03-13 | 2011-11-01 | Janssen Pharmaceutica N.V. | Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
US7119203B2 (en) * | 2002-04-25 | 2006-10-10 | Pharmacia Corporation | Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
GB0209715D0 (en) * | 2002-04-27 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
JP4027406B2 (ja) * | 2003-03-12 | 2007-12-26 | クドス ファーマシューティカルズ リミテッド | フタラジノン誘導体 |
ES2375134T3 (es) | 2003-07-30 | 2012-02-27 | Xenon Pharmaceuticals Inc. | Derivados de piperazina y su uso como agentes terapéuticos. |
-
2004
- 2004-07-29 KR KR1020067002003A patent/KR20060037409A/ko not_active Application Discontinuation
- 2004-07-29 AT AT04779656T patent/ATE532772T1/de active
- 2004-07-29 PL PL04779656T patent/PL1651620T3/pl unknown
- 2004-07-29 AU AU2004261268A patent/AU2004261268B2/en not_active Ceased
- 2004-07-29 SI SI200431805T patent/SI1648874T1/sl unknown
- 2004-07-29 CA CA002533901A patent/CA2533901A1/en not_active Abandoned
- 2004-07-29 CN CN200910207686A patent/CN101693697A/zh active Pending
- 2004-07-29 EP EP04779656A patent/EP1651620B1/en active Active
- 2004-07-29 BR BRPI0412348-4A patent/BRPI0412348A/pt not_active IP Right Cessation
- 2004-07-29 US US10/567,009 patent/US7456180B2/en not_active Expired - Fee Related
- 2004-07-29 CN CNA2004800219422A patent/CN1829701A/zh active Pending
- 2004-07-29 JP JP2006522096A patent/JP4838128B2/ja not_active Expired - Fee Related
- 2004-07-29 CN CNB200480021867XA patent/CN100558713C/zh not_active Expired - Fee Related
- 2004-07-29 PT PT04779656T patent/PT1651620E/pt unknown
- 2004-07-29 EP EP10184745A patent/EP2316828A1/en not_active Withdrawn
- 2004-07-29 SG SG200805680-6A patent/SG145701A1/en unknown
- 2004-07-29 WO PCT/US2004/024658 patent/WO2005011657A2/en active Application Filing
- 2004-07-29 RU RU2006105717/04A patent/RU2006105717A/ru not_active Application Discontinuation
- 2004-07-29 ES ES04779656T patent/ES2377406T3/es active Active
-
2006
- 2006-01-05 ZA ZA200600125A patent/ZA200600125B/en unknown
- 2006-01-05 ZA ZA200600126A patent/ZA200600126B/en unknown
- 2006-01-25 EC EC2006006311A patent/ECSP066311A/es unknown
- 2006-01-26 IL IL173396A patent/IL173396A0/en unknown
- 2006-01-27 TN TNP2006000033A patent/TNSN06033A1/en unknown
- 2006-02-27 MA MA28838A patent/MA28010A1/fr unknown
- 2006-02-28 NO NO20060971A patent/NO20060971L/no not_active Application Discontinuation
-
2008
- 2008-10-08 US US12/247,792 patent/US8030488B2/en not_active Expired - Fee Related
-
2009
- 2009-06-11 AU AU2009202338A patent/AU2009202338A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007500720A5 (US07981874-20110719-C00313.png) | ||
JP6353460B2 (ja) | Hbv感染に対する抗ウイルス剤としての官能化ベンズアミド誘導体 | |
TWI236474B (en) | Antagonists of MCP-1 function and methods of use thereof | |
TWI339121B (en) | 1-piperazine- and 1-homopiperazine-carboxylate derivatives, preparation and therapeutic application thereof | |
JP2008513498A5 (US07981874-20110719-C00313.png) | ||
JP2008513516A5 (US07981874-20110719-C00313.png) | ||
AU2016323305A1 (en) | Hepatitis B core protein modulators | |
RU2493149C2 (ru) | Замещенные метилфенилкетоны, пригодные для использования в качестве ингибиторов pde4 | |
JP2010528114A (ja) | 脂肪酸アミド加水分解酵素のヘテロアリール置換尿素モジュレータ | |
JP2008513515A5 (US07981874-20110719-C00313.png) | ||
US11040963B2 (en) | Piperazine derivatives for influenza virus inhibitions | |
SG192439A1 (en) | Organic compounds | |
AU2014310404B2 (en) | Amide derivatives as lysophosphatidic acid receptor antagonists | |
JP2005514455A (ja) | 芳香族チオエーテル肝臓x受容体モジュレータ | |
PT1142885E (pt) | Derivados de 2-(n-cianoimino)tiazolidin-4-ona | |
JP2008515884A (ja) | 新規なヒドロキシメチルベンゾチアゾールアミド | |
WO2019105234A1 (zh) | 芳香族化合物及其药物组合物和用途 | |
JP2014518281A (ja) | 電位依存性ナトリウムチャネル遮断薬 | |
EP3154634B1 (en) | Imidazol- or 1,2,4-triazol-derivatives and their use | |
BR112014028632B1 (pt) | composto, composição farmacêutica, e, método para preparar um composto | |
KR20010102390A (ko) | 폴리사이클릭 2-아미노-티아졸 시스템, 이의 제조방법 및이를 함유하는 약제 | |
WO2004069788A1 (ja) | カルボン酸化合物 | |
CN102137851B (zh) | 作为香草素受体拮抗剂的化合物、其异构体或其药学可接受的盐以及包含它们的药物组合物 | |
WO2017042380A1 (en) | Novel 5-amino-2-thioimidazole compounds and their use | |
JPH05125038A (ja) | フエノキシアルカン酸誘導体及びその製法 |